EE200300095A - Ravimi transdermaalse transpordi vähenemise pärssimise meetodid kanalite sulgumise pärssimisega - Google Patents

Ravimi transdermaalse transpordi vähenemise pärssimise meetodid kanalite sulgumise pärssimisega

Info

Publication number
EE200300095A
EE200300095A EEP200300095A EEP200300095A EE200300095A EE 200300095 A EE200300095 A EE 200300095A EE P200300095 A EEP200300095 A EE P200300095A EE P200300095 A EEP200300095 A EE P200300095A EE 200300095 A EE200300095 A EE 200300095A
Authority
EE
Estonia
Prior art keywords
inhibiting
agent
decrease
methods
sampling
Prior art date
Application number
EEP200300095A
Other languages
English (en)
Inventor
Lin Weiqi
J. N. Cormier Michel
E. Daddona Peter
A. Johnson Juanita
A. Matriano James
Original Assignee
Alza Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corporation filed Critical Alza Corporation
Publication of EE200300095A publication Critical patent/EE200300095A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
EEP200300095A 2000-09-08 2001-09-06 Ravimi transdermaalse transpordi vähenemise pärssimise meetodid kanalite sulgumise pärssimisega EE200300095A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23116000P 2000-09-08 2000-09-08
PCT/US2001/027551 WO2002019985A2 (en) 2000-09-08 2001-09-06 Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure

Publications (1)

Publication Number Publication Date
EE200300095A true EE200300095A (et) 2005-02-15

Family

ID=22867983

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300095A EE200300095A (et) 2000-09-08 2001-09-06 Ravimi transdermaalse transpordi vähenemise pärssimise meetodid kanalite sulgumise pärssimisega

Country Status (24)

Country Link
US (1) US7438926B2 (et)
EP (1) EP1335711B1 (et)
JP (2) JP5507030B2 (et)
KR (1) KR100764699B1 (et)
CN (1) CN100421653C (et)
AT (1) ATE367805T1 (et)
AU (2) AU8877401A (et)
BR (1) BR0113749A (et)
CA (1) CA2422200A1 (et)
CZ (1) CZ2003687A3 (et)
DE (1) DE60129585T2 (et)
DK (1) DK1335711T3 (et)
EE (1) EE200300095A (et)
ES (1) ES2290166T3 (et)
IL (1) IL154811A0 (et)
MA (1) MA25958A1 (et)
MX (1) MXPA03002122A (et)
NO (1) NO20031071L (et)
NZ (1) NZ524646A (et)
PL (1) PL365603A1 (et)
PT (1) PT1335711E (et)
RU (1) RU2272618C2 (et)
WO (1) WO2002019985A2 (et)
ZA (1) ZA200302700B (et)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5507030B2 (ja) * 2000-09-08 2014-05-28 アルザ・コーポレーシヨン 経路閉鎖を阻害することによる経皮的薬物流動の減少の抑制方法
NZ525551A (en) * 2000-10-26 2005-09-30 Alza Corp Transdermal drug delivery devices having coated microprotrusions
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
KR20060038407A (ko) 2003-06-30 2006-05-03 알자 코포레이션 비휘발성 반대이온을 포함하는 코팅된 미세돌출부용 제제
CN1845708A (zh) * 2003-07-02 2006-10-11 阿尔扎公司 微突出物阵列免疫贴剂和方法
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds
WO2005042702A2 (en) * 2003-10-23 2005-05-12 Alza Corporation Compositions of stabilized dna for coating microprojections
BRPI0415466A (pt) * 2003-10-24 2006-12-19 Alza Corp método e sistema de pré-tratamento para intensificar a distribuição transdérmica de fármacos
KR20070010115A (ko) * 2003-11-13 2007-01-22 알자 코포레이션 경피전달용 조성물 및 장치
KR20060135931A (ko) 2004-04-01 2006-12-29 알자 코포레이션 인플루엔자 백신의 경피전달 장치 및 방법
CA2562731A1 (en) * 2004-04-13 2005-11-03 Alza Corporation Apparatus and method for transdermal delivery of fentanyl-based agents
CN101120101A (zh) * 2004-04-13 2008-02-06 阿尔扎公司 多联疫苗透皮释放的装置和方法
WO2006020841A2 (en) * 2004-08-11 2006-02-23 Alza Corporation Apparatus and method for transdermal delivery of natriuretic peptides
WO2006055799A1 (en) * 2004-11-18 2006-05-26 3M Innovative Properties Company Masking method for coating a microneedle array
WO2006055844A2 (en) 2004-11-18 2006-05-26 3M Innovative Properties Company Method of contact coating a microneedle array
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
JP2008530230A (ja) * 2005-02-16 2008-08-07 アルザ・コーポレーシヨン エリスロポエチンに基づく剤の経皮送達のための装置および方法
US20070270738A1 (en) * 2005-04-25 2007-11-22 Wu Jeffrey M Method of treating ACNE with stratum corneum piercing patch
US20060253078A1 (en) * 2005-04-25 2006-11-09 Wu Jeffrey M Method of treating skin disorders with stratum corneum piercing device
EP1904158B1 (en) 2005-06-24 2013-07-24 3M Innovative Properties Company Collapsible patch with microneedle array
US20070078414A1 (en) * 2005-08-05 2007-04-05 Mcallister Devin V Methods and devices for delivering agents across biological barriers
CA2629193C (en) * 2005-11-18 2016-03-29 3M Innovative Properties Company Coatable compositions, coatings derived therefrom and microarrays having such coatings
EP2018835B1 (de) * 2007-07-09 2014-03-05 Augustinus Bader Wirkstoff abgebendes Pflaster
US8617487B2 (en) 2009-03-25 2013-12-31 Venture Lending & Leasing Vi, Inc. Saliva sample collection systems
WO2011010456A1 (ja) * 2009-07-24 2011-01-27 株式会社ネクスト２１ ＮＳＡＩＤｓ含有外用剤及び当該外用剤の製造方法
EP2818159A1 (de) * 2013-06-25 2014-12-31 LTS LOHMANN Therapie-Systeme AG Vorrichtung mit transdermalem therapeutischem System, Positionier- und Penetrationshilfe
US9987361B1 (en) * 2014-12-29 2018-06-05 Noven Pharmaceuticals, Inc. Compositions and method for sustained drug delivery by active transdermal technology
DE102017126501A1 (de) 2017-11-10 2019-05-16 Lts Lohmann Therapie-Systeme Ag Mikronadelsystem zur Applikation eines Hepatitis-Impfstoffes
US20190231925A1 (en) * 2018-01-31 2019-08-01 Changchun Ja Biotech. Co., Ltd. Heparin sodium supported hydrogel sustained-release paster

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25637E (en) 1964-09-08 Means for vaccinating
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (fr) 1972-02-14 1973-08-13 Ici Ltd Pansements
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5279544A (en) 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
GB9118028D0 (en) * 1991-08-21 1991-10-09 Secr Defence Brit Improved transdrmal formulations
IL109037A (en) * 1993-03-19 1999-01-26 Cellegy Pharma Inc Preparations for causing phase separation of lipid layers and preparation of the above preparations
US5458140A (en) 1993-11-15 1995-10-17 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
JPH10510175A (ja) * 1994-12-09 1998-10-06 ノバルティス アクチェンゲゼルシャフト 経皮システム
AU5869796A (en) 1995-05-22 1996-12-11 Ned A. Godshall Micromechanical patch for enhancing the delivery of compound s through the skin
WO1996037155A1 (en) 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Micromechanical device and method for enhancing delivery of compounds through the skin
DE19525607A1 (de) * 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneales Arzneimittelfreigabesystem
US5902603A (en) * 1995-09-14 1999-05-11 Cygnus, Inc. Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
CA2253549C (en) * 1996-06-18 2005-10-25 Alza Corporation Device for enhancing transdermal agent delivery or sampling
ATE241405T1 (de) 1996-07-03 2003-06-15 Altea Therapeutics Corp Mehrfache mechanische mikroperforierung von haut oder schleimhäuten
US5983136A (en) 1996-09-17 1999-11-09 Deka Products Limited Partnership System for delivery of drugs by transport
EP0957972B1 (en) 1996-12-20 2003-03-19 Alza Corporation Device and method for enhancing transdermal agent flux
DE19654391A1 (de) 1996-12-27 1998-07-02 Basf Ag Katalysator zur selektiven Herstellung von Propylen aus Propan
EP0952850A2 (en) * 1996-12-31 1999-11-03 Altea Technologies, Inc. Microporation of tissue for delivery of bioactive agents
US6918901B1 (en) 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
DE69806963T2 (de) * 1997-12-11 2002-11-21 Alza Corp., Mountain View Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
CA2313698C (en) * 1997-12-11 2008-04-15 Alza Corporation Device for enhancing transdermal agent flux
ES2314995T3 (es) 1997-12-11 2009-03-16 Alza Corporation Dispositivo para mejorar el flujo de agentes tansdermicos.
US6022316A (en) 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications
EP1086214B1 (en) 1998-06-10 2009-11-25 Georgia Tech Research Corporation Microneedle devices and methods of their manufacture
CA2372919A1 (en) * 1999-05-17 2000-11-23 Kevin S. Machitto Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
CA2376128C (en) * 1999-06-04 2009-01-06 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
ES2253278T3 (es) * 1999-12-10 2006-06-01 Alza Corporation Dispositivo y procedimiento para mejorar la perforacion cutanea con microprotuberancias.
MXPA02005765A (es) * 1999-12-10 2003-01-28 Alza Corp Aparato de tratamiento de piel para el suministro de farmaco transdermico sostenido.
JP5507030B2 (ja) * 2000-09-08 2014-05-28 アルザ・コーポレーシヨン 経路閉鎖を阻害することによる経皮的薬物流動の減少の抑制方法
NZ525551A (en) * 2000-10-26 2005-09-30 Alza Corp Transdermal drug delivery devices having coated microprotrusions
EP1590033A2 (en) * 2002-09-30 2005-11-02 Alza Corporation Drug delivery device having coated microprojections incorporating vasoconstrictors

Also Published As

Publication number Publication date
KR100764699B1 (ko) 2007-10-08
BR0113749A (pt) 2004-06-22
JP2004508319A (ja) 2004-03-18
EP1335711A2 (en) 2003-08-20
CA2422200A1 (en) 2002-03-14
PL365603A1 (en) 2005-01-10
WO2002019985A2 (en) 2002-03-14
CN100421653C (zh) 2008-10-01
DE60129585T2 (de) 2008-04-17
DE60129585D1 (de) 2007-09-06
JP2013256500A (ja) 2013-12-26
CN1473037A (zh) 2004-02-04
IL154811A0 (en) 2003-10-31
ATE367805T1 (de) 2007-08-15
MXPA03002122A (es) 2004-09-10
NO20031071L (no) 2003-05-06
AU2001288774B2 (en) 2006-06-29
DK1335711T3 (da) 2007-11-26
NO20031071D0 (no) 2003-03-07
US7438926B2 (en) 2008-10-21
EP1335711B1 (en) 2007-07-25
RU2272618C2 (ru) 2006-03-27
WO2002019985A3 (en) 2002-09-06
PT1335711E (pt) 2007-09-05
NZ524646A (en) 2004-10-29
ES2290166T3 (es) 2008-02-16
ZA200302700B (en) 2004-08-13
CZ2003687A3 (cs) 2004-01-14
KR20030074595A (ko) 2003-09-19
US20020102292A1 (en) 2002-08-01
MA25958A1 (fr) 2003-12-31
AU8877401A (en) 2002-03-22
JP5507030B2 (ja) 2014-05-28

Similar Documents

Publication Publication Date Title
EE200300095A (et) Ravimi transdermaalse transpordi vähenemise pärssimise meetodid kanalite sulgumise pärssimisega
PL363079A1 (en) Transdermal patch for administering fentanyl
BR0312671A (pt) Dispositivo de microagulhas, método para utilizar um dispositivo de microagulhas, e, método para aplicar um dispositivo de microagulhas
EA200301200A1 (ru) Проникающая через кожу композиция селективного ингибитора циклооксигеназы-2
WO2004006906A3 (en) Methods for the treatment of neoplasms
ES2017195A6 (es) Forma de dosificacion que tiene reducidas posiblidades de abuso.
BR9807816A (pt) Permeação anestésica tópica assistida a laser
CY1111263T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει sns-595 και χρησεις αυτης
EA200501702A1 (ru) Устойчивая к манипуляциям дозировочная форма для трансдермального введения
CY1109070T1 (el) Διαδερμικη μορφη δοσολογιας περιλαμβανουσα ενα δραστικο παραγοντα και ενα αλας και μια μορφη ελευθερης βασεως ενος ανταγωνιστη
DK0764020T3 (da) Transdermalt system til indgivelse af lægemiddel
MXPA06001110A (es) Uso de una combinacion de un inhibidor de la cinasa del receptor del factor de crecimiento epidermico y agentes citotoxicos para el tratamiento e inhibicion del cancer.
TW200605929A (en) Method and apparatus for reducing the incidence of tobacco use
DE50006156D1 (de) Vorrichtung und verwendung zur steigerung der transdermalen permeation von arzneistoffen
WO2002049630A3 (en) Method for preventing or treating pain by administering an endothelin antagonist
DE60112248D1 (de) Allzweck -medikament und -wärmebehandlungssystem
HUP0200189A2 (hu) Nikotintartalmú transzdermális rendszer
DE60213116D1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
WO2007103190A3 (en) Transdermal treatment of tendinop athy using no donor
DK1638492T3 (da) Præoperativ behandling af postoperativ smerte
AU2002228314A1 (en) Means for retaining transcutaneous catheters and needles in place
WO2005097083A3 (en) Transdermal administration of proton pump inhibitors
WO2001000191A3 (en) Use of fosphenytion for the treatment of acute neuropathic pain
TW200614985A (en) Compositions for the treatment of inflammation and pain using a combination of an NSAID and LTB4 receptor antagonist